nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—Gastrointestinal discomfort—Lamivudine—hepatitis B	0.0296	0.0296	CcSEcCtD
Metronidazole—Localised oedema—Lamivudine—hepatitis B	0.0266	0.0266	CcSEcCtD
Metronidazole—Sickness—Lamivudine—hepatitis B	0.0242	0.0242	CcSEcCtD
Metronidazole—Loose stools—Telbivudine—hepatitis B	0.0216	0.0216	CcSEcCtD
Metronidazole—Influenza-like symptoms—Telbivudine—hepatitis B	0.0167	0.0167	CcSEcCtD
Metronidazole—Pregnancy—Lamivudine—hepatitis B	0.0119	0.0119	CcSEcCtD
Metronidazole—Hepatic failure—Entecavir—hepatitis B	0.0117	0.0117	CcSEcCtD
Metronidazole—Influenza like illness—Telbivudine—hepatitis B	0.0116	0.0116	CcSEcCtD
Metronidazole—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.0115	0.0115	CcSEcCtD
Metronidazole—Breast enlargement—Lamivudine—hepatitis B	0.0104	0.0104	CcSEcCtD
Metronidazole—Abdominal cramps—Lamivudine—hepatitis B	0.00997	0.00997	CcSEcCtD
Metronidazole—Bone marrow depression—Lamivudine—hepatitis B	0.00997	0.00997	CcSEcCtD
Metronidazole—Abdominal pain upper—Entecavir—hepatitis B	0.00963	0.00963	CcSEcCtD
Metronidazole—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.0095	0.0095	CcSEcCtD
Metronidazole—Pancreatitis—Entecavir—hepatitis B	0.00894	0.00894	CcSEcCtD
Metronidazole—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00872	0.00872	CcSEcCtD
Metronidazole—Neutropenia—Entecavir—hepatitis B	0.00852	0.00852	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Entecavir—hepatitis B	0.00847	0.00847	CcSEcCtD
Metronidazole—Blood disorder—Lamivudine—hepatitis B	0.00805	0.00805	CcSEcCtD
Metronidazole—Abdominal pain upper—Telbivudine—hepatitis B	0.00791	0.00791	CcSEcCtD
Metronidazole—Cramp muscle—Telbivudine—hepatitis B	0.0078	0.0078	CcSEcCtD
Metronidazole—Nasopharyngitis—Telbivudine—hepatitis B	0.00775	0.00775	CcSEcCtD
Metronidazole—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00773	0.00773	CcSEcCtD
Metronidazole—Hepatobiliary disease—Entecavir—hepatitis B	0.00769	0.00769	CcSEcCtD
Metronidazole—Abdominal distension—Telbivudine—hepatitis B	0.00754	0.00754	CcSEcCtD
Metronidazole—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0075	0.0075	CcSEcCtD
Metronidazole—Influenza—Telbivudine—hepatitis B	0.00749	0.00749	CcSEcCtD
Metronidazole—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00744	0.00744	CcSEcCtD
Metronidazole—Hepatitis—Entecavir—hepatitis B	0.0073	0.0073	CcSEcCtD
Metronidazole—Abdominal discomfort—Telbivudine—hepatitis B	0.00718	0.00718	CcSEcCtD
Metronidazole—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00712	0.00712	CcSEcCtD
Metronidazole—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00707	0.00707	CcSEcCtD
Metronidazole—Neutropenia—Telbivudine—hepatitis B	0.007	0.007	CcSEcCtD
Metronidazole—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.007	0.007	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00696	0.00696	CcSEcCtD
Metronidazole—Eructation—Lamivudine—hepatitis B	0.00661	0.00661	CcSEcCtD
Metronidazole—Immune system disorder—Entecavir—hepatitis B	0.00659	0.00659	CcSEcCtD
Metronidazole—Neuropathy peripheral—Telbivudine—hepatitis B	0.00655	0.00655	CcSEcCtD
Metronidazole—Mental disorder—Entecavir—hepatitis B	0.00639	0.00639	CcSEcCtD
Metronidazole—Aplastic anaemia—Lamivudine—hepatitis B	0.00632	0.00632	CcSEcCtD
Metronidazole—Neuropathy—Lamivudine—hepatitis B	0.00632	0.00632	CcSEcCtD
Metronidazole—Hepatobiliary disease—Telbivudine—hepatitis B	0.00632	0.00632	CcSEcCtD
Metronidazole—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00611	0.00611	CcSEcCtD
Metronidazole—Urine output increased—Lamivudine—hepatitis B	0.00608	0.00608	CcSEcCtD
Metronidazole—Gynaecomastia—Lamivudine—hepatitis B	0.00602	0.00602	CcSEcCtD
Metronidazole—Back pain—Adefovir Dipivoxil—hepatitis B	0.006	0.006	CcSEcCtD
Metronidazole—Hepatitis—Telbivudine—hepatitis B	0.00599	0.00599	CcSEcCtD
Metronidazole—Hypoaesthesia—Telbivudine—hepatitis B	0.00596	0.00596	CcSEcCtD
Metronidazole—Pharyngitis—Telbivudine—hepatitis B	0.00595	0.00595	CcSEcCtD
Metronidazole—Connective tissue disorder—Telbivudine—hepatitis B	0.00589	0.00589	CcSEcCtD
Metronidazole—Leukopenia—Entecavir—hepatitis B	0.00569	0.00569	CcSEcCtD
Metronidazole—Polyuria—Lamivudine—hepatitis B	0.00556	0.00556	CcSEcCtD
Metronidazole—Mediastinal disorder—Telbivudine—hepatitis B	0.0054	0.0054	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00537	0.00537	CcSEcCtD
Metronidazole—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00528	0.00528	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00524	0.00524	CcSEcCtD
Metronidazole—Anaphylactic shock—Entecavir—hepatitis B	0.00518	0.00518	CcSEcCtD
Metronidazole—Infection—Entecavir—hepatitis B	0.00515	0.00515	CcSEcCtD
Metronidazole—Dysgeusia—Telbivudine—hepatitis B	0.00511	0.00511	CcSEcCtD
Metronidazole—Nervous system disorder—Entecavir—hepatitis B	0.00508	0.00508	CcSEcCtD
Metronidazole—Back pain—Telbivudine—hepatitis B	0.00505	0.00505	CcSEcCtD
Metronidazole—Skin disorder—Entecavir—hepatitis B	0.00504	0.00504	CcSEcCtD
Metronidazole—Muscle spasms—Telbivudine—hepatitis B	0.00502	0.00502	CcSEcCtD
Metronidazole—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00496	0.00496	CcSEcCtD
Metronidazole—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00495	0.00495	CcSEcCtD
Metronidazole—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00491	0.00491	CcSEcCtD
Metronidazole—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00482	0.00482	CcSEcCtD
Metronidazole—Malaise—Telbivudine—hepatitis B	0.00471	0.00471	CcSEcCtD
Metronidazole—Insomnia—Entecavir—hepatitis B	0.00469	0.00469	CcSEcCtD
Metronidazole—Somnolence—Entecavir—hepatitis B	0.00461	0.00461	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00461	0.00461	CcSEcCtD
Metronidazole—Dyspepsia—Entecavir—hepatitis B	0.00456	0.00456	CcSEcCtD
Metronidazole—Liver function test abnormal—Lamivudine—hepatitis B	0.00451	0.00451	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Entecavir—hepatitis B	0.00448	0.00448	CcSEcCtD
Metronidazole—Fatigue—Entecavir—hepatitis B	0.00447	0.00447	CcSEcCtD
Metronidazole—Abdominal pain upper—Lamivudine—hepatitis B	0.00446	0.00446	CcSEcCtD
Metronidazole—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00445	0.00445	CcSEcCtD
Metronidazole—Chest pain—Telbivudine—hepatitis B	0.00444	0.00444	CcSEcCtD
Metronidazole—Arthralgia—Telbivudine—hepatitis B	0.00444	0.00444	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00441	0.00441	CcSEcCtD
Metronidazole—Cramp muscle—Lamivudine—hepatitis B	0.0044	0.0044	CcSEcCtD
Metronidazole—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0044	0.0044	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00437	0.00437	CcSEcCtD
Metronidazole—Nasopharyngitis—Lamivudine—hepatitis B	0.00437	0.00437	CcSEcCtD
Metronidazole—Abdominal distension—Lamivudine—hepatitis B	0.00425	0.00425	CcSEcCtD
Metronidazole—Gastrointestinal pain—Entecavir—hepatitis B	0.00424	0.00424	CcSEcCtD
Metronidazole—Influenza—Lamivudine—hepatitis B	0.00422	0.00422	CcSEcCtD
Metronidazole—Nervous system disorder—Telbivudine—hepatitis B	0.00418	0.00418	CcSEcCtD
Metronidazole—Thrombocytopenia—Telbivudine—hepatitis B	0.00417	0.00417	CcSEcCtD
Metronidazole—Pancreatitis—Lamivudine—hepatitis B	0.00414	0.00414	CcSEcCtD
Metronidazole—Skin disorder—Telbivudine—hepatitis B	0.00414	0.00414	CcSEcCtD
Metronidazole—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00414	0.00414	CcSEcCtD
Metronidazole—Abdominal pain—Entecavir—hepatitis B	0.0041	0.0041	CcSEcCtD
Metronidazole—Body temperature increased—Entecavir—hepatitis B	0.0041	0.0041	CcSEcCtD
Metronidazole—Bronchitis—Lamivudine—hepatitis B	0.00406	0.00406	CcSEcCtD
Metronidazole—Abdominal discomfort—Lamivudine—hepatitis B	0.00405	0.00405	CcSEcCtD
Metronidazole—Pancytopenia—Lamivudine—hepatitis B	0.00401	0.00401	CcSEcCtD
Metronidazole—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.004	0.004	CcSEcCtD
Metronidazole—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.004	0.004	CcSEcCtD
Metronidazole—Neutropenia—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Metronidazole—Dysuria—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Metronidazole—Pollakiuria—Lamivudine—hepatitis B	0.0039	0.0039	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00388	0.00388	CcSEcCtD
Metronidazole—Insomnia—Telbivudine—hepatitis B	0.00385	0.00385	CcSEcCtD
Metronidazole—Paraesthesia—Telbivudine—hepatitis B	0.00382	0.00382	CcSEcCtD
Metronidazole—Depression—Lamivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Metronidazole—Dyspepsia—Telbivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00373	0.00373	CcSEcCtD
Metronidazole—Asthenia—Entecavir—hepatitis B	0.00372	0.00372	CcSEcCtD
Metronidazole—Neuropathy peripheral—Lamivudine—hepatitis B	0.00369	0.00369	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00368	0.00368	CcSEcCtD
Metronidazole—Fatigue—Telbivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Metronidazole—Stomatitis—Lamivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Metronidazole—Jaundice—Lamivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Metronidazole—Pain—Telbivudine—hepatitis B	0.00364	0.00364	CcSEcCtD
Metronidazole—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00363	0.00363	CcSEcCtD
Metronidazole—Sweating—Lamivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Metronidazole—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00358	0.00358	CcSEcCtD
Metronidazole—Hepatobiliary disease—Lamivudine—hepatitis B	0.00356	0.00356	CcSEcCtD
Metronidazole—Diarrhoea—Entecavir—hepatitis B	0.00355	0.00355	CcSEcCtD
Metronidazole—Sinusitis—Lamivudine—hepatitis B	0.00353	0.00353	CcSEcCtD
Metronidazole—Agranulocytosis—Lamivudine—hepatitis B	0.00351	0.00351	CcSEcCtD
Metronidazole—Feeling abnormal—Telbivudine—hepatitis B	0.00351	0.00351	CcSEcCtD
Metronidazole—Gastrointestinal pain—Telbivudine—hepatitis B	0.00348	0.00348	CcSEcCtD
Metronidazole—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00346	0.00346	CcSEcCtD
Metronidazole—Dizziness—Entecavir—hepatitis B	0.00343	0.00343	CcSEcCtD
Metronidazole—Rhinitis—Lamivudine—hepatitis B	0.00339	0.00339	CcSEcCtD
Metronidazole—Hepatitis—Lamivudine—hepatitis B	0.00338	0.00338	CcSEcCtD
Metronidazole—Body temperature increased—Telbivudine—hepatitis B	0.00337	0.00337	CcSEcCtD
Metronidazole—Abdominal pain—Telbivudine—hepatitis B	0.00337	0.00337	CcSEcCtD
Metronidazole—Hypoaesthesia—Lamivudine—hepatitis B	0.00336	0.00336	CcSEcCtD
Metronidazole—Pharyngitis—Lamivudine—hepatitis B	0.00335	0.00335	CcSEcCtD
Metronidazole—Connective tissue disorder—Lamivudine—hepatitis B	0.00332	0.00332	CcSEcCtD
Metronidazole—Vomiting—Entecavir—hepatitis B	0.0033	0.0033	CcSEcCtD
Metronidazole—Rash—Entecavir—hepatitis B	0.00327	0.00327	CcSEcCtD
Metronidazole—Dermatitis—Entecavir—hepatitis B	0.00327	0.00327	CcSEcCtD
Metronidazole—Headache—Entecavir—hepatitis B	0.00325	0.00325	CcSEcCtD
Metronidazole—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00322	0.00322	CcSEcCtD
Metronidazole—Erythema multiforme—Lamivudine—hepatitis B	0.00319	0.00319	CcSEcCtD
Metronidazole—Rash—Adefovir Dipivoxil—hepatitis B	0.00319	0.00319	CcSEcCtD
Metronidazole—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00319	0.00319	CcSEcCtD
Metronidazole—Headache—Adefovir Dipivoxil—hepatitis B	0.00317	0.00317	CcSEcCtD
Metronidazole—Nausea—Entecavir—hepatitis B	0.00308	0.00308	CcSEcCtD
Metronidazole—Asthenia—Telbivudine—hepatitis B	0.00306	0.00306	CcSEcCtD
Metronidazole—Immune system disorder—Lamivudine—hepatitis B	0.00305	0.00305	CcSEcCtD
Metronidazole—Mediastinal disorder—Lamivudine—hepatitis B	0.00304	0.00304	CcSEcCtD
Metronidazole—Pruritus—Telbivudine—hepatitis B	0.00301	0.00301	CcSEcCtD
Metronidazole—Nausea—Adefovir Dipivoxil—hepatitis B	0.003	0.003	CcSEcCtD
Metronidazole—Erythema—Lamivudine—hepatitis B	0.00294	0.00294	CcSEcCtD
Metronidazole—Diarrhoea—Telbivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Metronidazole—Flatulence—Lamivudine—hepatitis B	0.0029	0.0029	CcSEcCtD
Metronidazole—Dysgeusia—Lamivudine—hepatitis B	0.00288	0.00288	CcSEcCtD
Metronidazole—Back pain—Lamivudine—hepatitis B	0.00284	0.00284	CcSEcCtD
Metronidazole—Muscle spasms—Lamivudine—hepatitis B	0.00283	0.00283	CcSEcCtD
Metronidazole—Dizziness—Telbivudine—hepatitis B	0.00282	0.00282	CcSEcCtD
Metronidazole—Tremor—Lamivudine—hepatitis B	0.00276	0.00276	CcSEcCtD
Metronidazole—Vomiting—Telbivudine—hepatitis B	0.00271	0.00271	CcSEcCtD
Metronidazole—Angioedema—Lamivudine—hepatitis B	0.00269	0.00269	CcSEcCtD
Metronidazole—Rash—Telbivudine—hepatitis B	0.00269	0.00269	CcSEcCtD
Metronidazole—Dermatitis—Telbivudine—hepatitis B	0.00268	0.00268	CcSEcCtD
Metronidazole—Headache—Telbivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Metronidazole—Malaise—Lamivudine—hepatitis B	0.00265	0.00265	CcSEcCtD
Metronidazole—Vertigo—Lamivudine—hepatitis B	0.00264	0.00264	CcSEcCtD
Metronidazole—Syncope—Lamivudine—hepatitis B	0.00264	0.00264	CcSEcCtD
Metronidazole—Leukopenia—Lamivudine—hepatitis B	0.00263	0.00263	CcSEcCtD
Metronidazole—Loss of consciousness—Lamivudine—hepatitis B	0.00258	0.00258	CcSEcCtD
Metronidazole—Convulsion—Lamivudine—hepatitis B	0.00255	0.00255	CcSEcCtD
Metronidazole—Nausea—Telbivudine—hepatitis B	0.00253	0.00253	CcSEcCtD
Metronidazole—Chest pain—Lamivudine—hepatitis B	0.0025	0.0025	CcSEcCtD
Metronidazole—Arthralgia—Lamivudine—hepatitis B	0.0025	0.0025	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00249	0.00249	CcSEcCtD
Metronidazole—Dry mouth—Lamivudine—hepatitis B	0.00245	0.00245	CcSEcCtD
Metronidazole—Confusional state—Lamivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Metronidazole—Anaphylactic shock—Lamivudine—hepatitis B	0.0024	0.0024	CcSEcCtD
Metronidazole—Oedema—Lamivudine—hepatitis B	0.0024	0.0024	CcSEcCtD
Metronidazole—Infection—Lamivudine—hepatitis B	0.00238	0.00238	CcSEcCtD
Metronidazole—Shock—Lamivudine—hepatitis B	0.00236	0.00236	CcSEcCtD
Metronidazole—Nervous system disorder—Lamivudine—hepatitis B	0.00235	0.00235	CcSEcCtD
Metronidazole—Thrombocytopenia—Lamivudine—hepatitis B	0.00235	0.00235	CcSEcCtD
Metronidazole—Skin disorder—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Metronidazole—Hyperhidrosis—Lamivudine—hepatitis B	0.00232	0.00232	CcSEcCtD
Metronidazole—Anorexia—Lamivudine—hepatitis B	0.00229	0.00229	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00219	0.00219	CcSEcCtD
Metronidazole—Insomnia—Lamivudine—hepatitis B	0.00217	0.00217	CcSEcCtD
Metronidazole—Paraesthesia—Lamivudine—hepatitis B	0.00216	0.00216	CcSEcCtD
Metronidazole—Somnolence—Lamivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Metronidazole—Dyspepsia—Lamivudine—hepatitis B	0.00211	0.00211	CcSEcCtD
Metronidazole—Decreased appetite—Lamivudine—hepatitis B	0.00209	0.00209	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Metronidazole—Fatigue—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Metronidazole—Constipation—Lamivudine—hepatitis B	0.00205	0.00205	CcSEcCtD
Metronidazole—Pain—Lamivudine—hepatitis B	0.00205	0.00205	CcSEcCtD
Metronidazole—Feeling abnormal—Lamivudine—hepatitis B	0.00198	0.00198	CcSEcCtD
Metronidazole—Gastrointestinal pain—Lamivudine—hepatitis B	0.00196	0.00196	CcSEcCtD
Metronidazole—Urticaria—Lamivudine—hepatitis B	0.00191	0.00191	CcSEcCtD
Metronidazole—Abdominal pain—Lamivudine—hepatitis B	0.0019	0.0019	CcSEcCtD
Metronidazole—Body temperature increased—Lamivudine—hepatitis B	0.0019	0.0019	CcSEcCtD
Metronidazole—Hypersensitivity—Lamivudine—hepatitis B	0.00177	0.00177	CcSEcCtD
Metronidazole—Asthenia—Lamivudine—hepatitis B	0.00172	0.00172	CcSEcCtD
Metronidazole—Pruritus—Lamivudine—hepatitis B	0.0017	0.0017	CcSEcCtD
Metronidazole—Diarrhoea—Lamivudine—hepatitis B	0.00164	0.00164	CcSEcCtD
Metronidazole—Dizziness—Lamivudine—hepatitis B	0.00159	0.00159	CcSEcCtD
Metronidazole—Vomiting—Lamivudine—hepatitis B	0.00153	0.00153	CcSEcCtD
Metronidazole—Rash—Lamivudine—hepatitis B	0.00151	0.00151	CcSEcCtD
Metronidazole—Dermatitis—Lamivudine—hepatitis B	0.00151	0.00151	CcSEcCtD
Metronidazole—Headache—Lamivudine—hepatitis B	0.0015	0.0015	CcSEcCtD
Metronidazole—Nausea—Lamivudine—hepatitis B	0.00143	0.00143	CcSEcCtD
